https://www.selleckchem.com/products/WP1130.html
001) were longer for the MIMVS group. Postoperatively, MIMVS was associated with shorter initial ventilator times (6 vs 9.6 hrs, P 0.001) and hospital lengths of stay (7 vs. 8 days, p = 0.049), as well as blood product utilization rates (26.8% vs. 41.1%, p = 0.03). Thirty-day (0.0% vs 2.7%, P = 0.12) and 10-year survival (Log-rank, P = 0.661) were similar between groups. MIMVS is safe in patients with PH and provides traditional benefits of minimally invasive surgery including shorter initial ventilator times and hospital LOS, witho
Gefällt mir
Kommentar
Teilen
